- Home
- DSM vs PRQR Comparison
DSM vs PRQR Comparison
Compare DSM & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSM
- PRQR
- Stock Information
- Founded
- DSM 1989
- PRQR 2012
- Country
- DSM United States
- PRQR Netherlands
- Employees
- DSM N/A
- PRQR N/A
- Industry
- DSM Investment Managers
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- DSM Finance
- PRQR Health Care
- Exchange
- DSM Nasdaq
- PRQR Nasdaq
- Market Cap
- DSM 289.7M
- PRQR 309.5M
- IPO Year
- DSM N/A
- PRQR 2014
- Fundamental
- Price
- DSM $5.99
- PRQR $2.56
- Analyst Decision
- DSM
- PRQR Strong Buy
- Analyst Count
- DSM 0
- PRQR 6
- Target Price
- DSM N/A
- PRQR $8.17
- AVG Volume (30 Days)
- DSM 161.7K
- PRQR 296.6K
- Earning Date
- DSM 01-01-0001
- PRQR 03-12-2025
- Dividend Yield
- DSM 3.97%
- PRQR N/A
- EPS Growth
- DSM N/A
- PRQR N/A
- EPS
- DSM N/A
- PRQR N/A
- Revenue
- DSM N/A
- PRQR $20,506,357.00
- Revenue This Year
- DSM N/A
- PRQR $210.18
- Revenue Next Year
- DSM N/A
- PRQR $33.25
- P/E Ratio
- DSM N/A
- PRQR N/A
- Revenue Growth
- DSM N/A
- PRQR 306.68
- 52 Week Low
- DSM $4.69
- PRQR $1.61
- 52 Week High
- DSM $6.05
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- DSM 61.34
- PRQR 56.93
- Support Level
- DSM $5.85
- PRQR $2.47
- Resistance Level
- DSM $6.05
- PRQR $2.67
- Average True Range (ATR)
- DSM 0.05
- PRQR 0.18
- MACD
- DSM 0.01
- PRQR 0.07
- Stochastic Oscillator
- DSM 72.73
- PRQR 83.58
About DSM BNY Mellon Strategic Municipal Bond Fund Inc.
BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.